from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0681/-

LFCtreatmentdescriptionclass of inhibitor

-0.013

Amikacinug/mL Amikacintranslation

-0.347

Cap5-10ug/mL Capreomycintranslation

-0.216

Rox10-50 ug/mL Roxithromycintranslation

0.031

SM2-5 ug/mL Streptomycintranslation

-1.301

Tet5-10 ug/mL Tetracyclinetranslation

-0.087

Rif0.2-5ug/mL Rifampicintranscription

0.108

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.515

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.167

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.256

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.274

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.080

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.488

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.295

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.358

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.365

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.852

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.719

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.012

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.075

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.712

KCN5-20 ug/mL Potassium cyaniderespiration

-0.130

NaN30.2-2 mM Sodium aziderespiration

-1.092

Nigericin50 uM Nigericinrespiration

0.253

TRC10-150 ug/mL Triclosanrespiration

-1.482

TRZ10-25 ug/mL Thioridazinerespiration

0.363

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.691

menadione6-10 ug/mL Menadionerespiration

0.025

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.082

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.185

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.682

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.790

NRP_1Non-replicating persistence stage 1dosRassociated

-0.468

Amp0.2mg/mL AmpicillincellWall

0.143

Cephalexin20-100 ug/mL CephalexincellWall

0.306

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.345

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.358

EMB10-20 ug/mL EthambutolcellWall

0.185

Eta12-40 ug/mL EthionamidecellWall

0.532

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.002

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.066

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.590

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.059

BZA0.12 mg/mL BenzamidearomaticAmides

1.310

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.122

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.830

H2O24 mM hydrogen peroxideDNAdamaging

-0.332

Levo10 ug/mL LevofloxacinDNAdamaging

0.139

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.535

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.146

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.011

UVUV-irradiationDNAdamaging

-0.476

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.393

Antimycin12.5-50 ug/mL Antimycin A?

-0.480

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.512

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.243

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.340

PA8240.2-2 ug/mL PA-824?

1.106

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.595

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.517

Verapamil50 uM Verapamil?

-0.694

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.326

methoxatin10-20 ug/mL Methoxatin?